BioSpace News Archive

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX:TMD ) ( Nasdaq:TMDI ), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“ MIS ”), is pleased to announce today that it closed its previously announced registered direct offering priced at-the-market under Nasdaq rules for the p

BlueWillow Biologics® today announced that laboratory studies conducted by Public Health England (PHE) demonstrate NanoBio® Protect’s ability to kill COVID-19 virus in lab tests. NanoBio® Protect is an alcohol-free, over-the-counter (OTC) nasal antiseptic that is used to kill germs on the skin and is easy to apply with a standard cotton swab

PinCell, a biotechnology company developing novel therapies for rare dermatological diseases, announced today the appointment of Gabriella Camboni, M.D., as Chief Executive Officer of PinCell and Member of the Board of Directors, and Luigi Costa as Chairman of the Board

To meet the challenge of ensuring adequate food for the vulnerable senior population, whose needs have greatly increased due to the COVID-19 pandemic, Conviva Care Centers have stepped up to provide a donation of $2 million to support seven local Feeding America® member food banks in Florida and Texas.

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced approval of ELYXYB (celecoxib oral solution 25 mg/mL) by the U.S. Food and Drug Administration (USFDA). ELYXYB (previously known as DFN-15) is indicated for the acute treatment of migraine with or without aura in adults.

LakePharma announces that the company will be supplying the Mount Sinai Health System recombinant SARS-CoV-2 spike proteins to the Mount Sinai Laboratory as a component in its blood test for antibody response against SARS-CoV-2, the virus that causes the COVID-19 pandemic.

Tabrecta is the first and only U.S. Food and Drug Administration (FDA)-approved treatment for adult patients with metastatic non-small cell lung cancer (NSCLC) with a mutation that leads to MET exon 14 skipping (METex14)

COVID-19 has changed our world. As of April 27, 2020, the Johns Hopkins University Coronavirus Resource Center reported over 3 million cases of COVID-19 worldwide, including 979,077 in the United States.

Guardant Health, Inc. announced the company will be participating in the upcoming BofA Securities Virtual Healthcare Conference.

G1 Therapeutics, Inc., a clinical-stage oncology company, provided a corporate and financial update for the first quarter ended March 31, 2020.